RGC
Roberts, Glore & Co Portfolio holdings
AUM
$342M
This Quarter Return
-5.06%
1 Year Return
+15.34%
3 Year Return
+56.21%
5 Year Return
+102.72%
10 Year Return
+238.78%
AUM
$280M
AUM Growth
+$280M
(-6.9%)
Cap. Flow
+$8.26M
Cap. Flow
% of AUM
2.95%
Top 10 Holdings %
Top 10 Hldgs %
36.57%
Holding
194
New
4
Increased
41
Reduced
101
Closed
10
Top Buys
Top Sells
| 1 |
Vanguard Total Bond Market
BND
|
$526K |
| 2 |
Apple
AAPL
|
$370K |
| 3 |
Gilead Sciences
GILD
|
$336K |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
$333K |
| 5 |
Invesco Taxable Municipal Bond ETF
BAB
|
$331K |
Sector Composition
| 1 | Healthcare | 21.4% |
| 2 | Technology | 15.82% |
| 3 | Financials | 11.66% |
| 4 | Industrials | 9.01% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Arista Networks
ANET
$170B
| $2.47M | 0.88% |
21,860
-460
| -2% | -$51.9K |
|
|
27
Invesco Taxable Municipal Bond ETF
BAB
$899M
| $2.41M | 0.86% |
93,959
-12,915
| -12% | -$331K |
|
28
Sprott Physical Gold and Silver Trust
CEF
$6.4B
| $2.39M | 0.85% |
153,487
| – | – |
|
29
Exxon Mobil
XOM
$488B
| $2.32M | 0.83% |
26,571
-2,239
| -8% | -$195K |
|
30
RTX Corp
RTX
$211B
| $2.28M | 0.82% |
27,869
-234
| -0.8% | -$19.2K |
|
31
Walmart
WMT
$778B
| $2.27M | 0.81% |
17,506
-425
| -2% | -$55.1K |
|
|
WIA
32
Western Asset Inflation-Linked Income Fund
WIA
$196M
| $2.27M | 0.81% |
253,376
-25,014
| -9% | -$224K |
|
33
CVS Health
CVS
$93.8B
| $2.21M | 0.79% |
23,138
-435
| -2% | -$41.5K |
|
34
Amgen
AMGN
$153B
| $2.18M | 0.78% |
9,653
-148
| -2% | -$33.4K |
|
35
Quest Diagnostics
DGX
$20.1B
| $2.17M | 0.77% |
17,667
-70
| -0.4% | -$8.59K |
|
36
Centene
CNC
$14.5B
| $2.16M | 0.77% |
27,779
-2,243
| -7% | -$174K |
|
37
Intel
INTC
$105B
| $2.16M | 0.77% |
83,828
+965
| +1% | +$24.9K |
|
38
Procter & Gamble
PG
$371B
| $2.16M | 0.77% |
17,093
-1,279
| -7% | -$161K |
|
39
Bio-Techne
TECH
$8.18B
| $2M | 0.72% |
7,048
-58
| -0.8% | -$16.5K |
|
40
Vanguard Mega Cap Value ETF
MGV
$9.78B
| $1.97M | 0.7% |
21,932
-502
| -2% | -$45.1K |
|
41
Linde
LIN
$222B
| $1.94M | 0.69% |
7,194
-321
| -4% | -$86.5K |
|
42
Union Pacific
UNP
$130B
| $1.83M | 0.65% |
9,385
-90
| -0.9% | -$17.5K |
|
|
43
Gilead Sciences
GILD
$139B
| $1.83M | 0.65% |
29,611
-5,449
| -16% | -$336K |
|
44
Vanguard Small-Cap Value ETF
VBR
$31B
| $1.81M | 0.65% |
12,641
-805
| -6% | -$115K |
|
45
Becton Dickinson
BDX
$54.1B
| $1.8M | 0.64% |
8,093
+146
| +2% | +$32.5K |
|
46
C.H. Robinson
CHRW
$15.1B
| $1.77M | 0.63% |
18,395
-1,369
| -7% | -$132K |
|
47
Coca-Cola
KO
$296B
| $1.7M | 0.61% |
30,357
-555
| -2% | -$31.1K |
|
|
48
Vanguard Total Bond Market
BND
$133B
| $1.68M | 0.6% |
23,596
-7,368
| -24% | -$526K |
|
|
49
Vanguard Dividend Appreciation ETF
VIG
$94.5B
| $1.63M | 0.58% |
12,058
-2,460
| -17% | -$333K |
|
50
Vertex Pharmaceuticals
VRTX
$102B
| $1.61M | 0.57% |
5,546
-105
| -2% | -$30.4K |
|